These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9468024)
1. Synthesis and evaluation of a monocationic copper(II) radiopharmaceutical derived from N-(2-pyridylmethyl)-N'-(salicylaldimino)-1,3-propanediamine. Sri-Aran M; Mathias CJ; Lim JK; Green MA Nucl Med Biol; 1998 Feb; 25(2):107-10. PubMed ID: 9468024 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands. Ackerman LJ; West DX; Mathias CJ; Green MA Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194 [TBL] [Abstract][Full Text] [Related]
3. Preparation and biodistribution of copper-67 complexes with tetradentate Schiff-base ligands. John EK; Bott AJ; Green MA J Pharm Sci; 1994 Apr; 83(4):587-90. PubMed ID: 8046620 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biodistribution of a Lipophilic 64Cu-labeled monocationic Copper(II) complex. Packard AB; Kronauge JF; Barbarics E; Kiani S; Treves ST Nucl Med Biol; 2002 Apr; 29(3):289-94. PubMed ID: 11929697 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biodistribution of 64Cu-labeled monocationic diiminedioxime copper(II) complexes. Packard AB; Kronauge JF; Day PJ; Treves ST Nucl Med Biol; 1998 Aug; 25(6):531-7. PubMed ID: 9751419 [TBL] [Abstract][Full Text] [Related]
6. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato)copper(II) derivatives. John EK; Green MA J Med Chem; 1990 Jun; 33(6):1764-70. PubMed ID: 2342070 [TBL] [Abstract][Full Text] [Related]
8. Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution. Yoo J; Reichert DE; Welch MJ J Med Chem; 2004 Dec; 47(26):6625-37. PubMed ID: 15588098 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of gallium-68 tris(2-mercaptobenzyl)amine: a complex with brain and myocardial uptake. Cutler CS; Giron MC; Reichert DE; Snyder AZ; Herrero P; Anderson CJ; Quarless DA; Koch SA; Welch MJ Nucl Med Biol; 1999 Apr; 26(3):305-16. PubMed ID: 10363802 [TBL] [Abstract][Full Text] [Related]
10. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands. Sun X; Wuest M; Kovacs Z; Sherry AD; Motekaitis R; Wang Z; Martell AE; Welch MJ; Anderson CJ J Biol Inorg Chem; 2003 Jan; 8(1-2):217-25. PubMed ID: 12459917 [TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334 [TBL] [Abstract][Full Text] [Related]
12. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation. Oh SJ; Won KS; Moon DH; Cheon JH; Ha HJ; Jeong JM; Lee HK Nucl Med Commun; 2002 Jan; 23(1):75-81. PubMed ID: 11748441 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and formulation of [ Green MA; Mathias CJ Appl Radiat Isot; 2022 Apr; 182():110119. PubMed ID: 35093818 [TBL] [Abstract][Full Text] [Related]
14. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes. Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494 [TBL] [Abstract][Full Text] [Related]
15. A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+. Tsang BW; Mathias CJ; Green MA J Nucl Med; 1993 Jul; 34(7):1127-31. PubMed ID: 8315489 [TBL] [Abstract][Full Text] [Related]
16. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions. Lim JK; Mathias CJ; Green MA J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties. Boschi A; Uccelli L; Bolzati C; Duatti A; Sabba N; Moretti E; Di Domenico G; Zavattini G; Refosco F; Giganti M J Nucl Med; 2003 May; 44(5):806-14. PubMed ID: 12732683 [TBL] [Abstract][Full Text] [Related]
18. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone). Green MA Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756 [TBL] [Abstract][Full Text] [Related]
19. Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. Lewis JS; Lewis MR; Srinivasan A; Schmidt MA; Wang J; Anderson CJ J Med Chem; 1999 Apr; 42(8):1341-7. PubMed ID: 10212119 [TBL] [Abstract][Full Text] [Related]
20. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals. Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]